That was Innovate Biopharmaceuticals Inc (NASDAQ:INNT), an early-stage drug developer and part of a recent reverse merger. Heading into the year, BXC looked moderately attractive. The building products distributor had
Growth Capitalist (https://growthcapitalist.com/2018/04/8-stocks-that-surprised-investors-in-q1/)
That was Innovate Biopharmaceuticals Inc (NASDAQ:INNT), an early-stage drug developer and part of a recent reverse merger. Heading into the year, BXC looked moderately attractive. The building products distributor had